Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Adler, C. M. Articles by Breier, A. Search for Related Content PubMed Citation Articles by Adler, C. M. Articles by Breier, A. Neurotransmitters Schizophrenia Spectrum Disorders

Comparison of Ketamine-Induced Thought Disorder in Healthy Volunteers and Thought Disorder in Schizophrenia

OBJECTIVE: This study sought to determine whether thought disorder induced in healthy volunteers by the N-methyl-D-aspartic acid (NMDA) receptor antagonist ketamine resembles the thought disorder found in patients with schizophrenia. METHOD: The Scale for the Assessment of Thought, Language, and Communication was used to assess thought disorder in healthy volunteers (N=10) who received subanesthetic doses of ketamine and in a group of clinically stable inpatients with schizophrenia (N=15) who did not receive keta­mine. RESULTS: Mean scores on the Scale for the Assessment of Thought, Language, and Communication for patients with schizophrenia and healthy volunteers receiving ketamine did not differ significantly. Moreover, three of the four highest rated test items in both groups were the same. CONCLUSIONS: These data suggest that ketamine-induced thought disorder in healthy volunteers is not dissimilar to the thought disorder in patients with schizophrenia and provide support for the involvement of the NMDA receptor in a cardinal symptom of schizophrenia.

This article has been cited by other articles:

				G. D. Honey, P. R. Corlett, A. R. Absalom, M. Lee, E. Pomarol-Clotet, G. K. Murray, P. J. McKenna, E. T. Bullmore, D. K. Menon, and P. C. Fletcher Individual Differences in Psychotic Effects of Ketamine Are Predicted by Brain Function Measured under Placebo J. Neurosci., June 18, 2008; 28(25): 6295 - 6303. [Abstract] [Full Text] [PDF]

				J. F. W. Deakin, J. Lees, S. McKie, J. E. C. Hallak, S. R. Williams, and S. M. Dursun Glutamate and the Neural Basis of the Subjective Effects of Ketamine: A Pharmaco-Magnetic Resonance Imaging Study Arch Gen Psychiatry, February 1, 2008; 65(2): 154 - 164. [Abstract] [Full Text] [PDF]

				H. Homayoun and B. Moghaddam NMDA Receptor Hypofunction Produces Opposite Effects on Prefrontal Cortex Interneurons and Pyramidal Neurons J. Neurosci., October 24, 2007; 27(43): 11496 - 11500. [Abstract] [Full Text] [PDF]

				C. H. Large Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs? J Psychopharmacol, May 1, 2007; 21(3): 283 - 301. [Abstract] [PDF]

				M. A. Covington, W. J. Riedel, C. Brown, C. He, E. Morris, S. Weinstein, J. SempLe, and J. Brown Does ketamine mimic aspects of schizophrenic speech? J Psychopharmacol, May 1, 2007; 21(3): 338 - 346. [Abstract] [PDF]

				D. A. Lewis and B. Moghaddam Cognitive Dysfunction in Schizophrenia: Convergence of {gamma}-Aminobutyric Acid and Glutamate Alterations. Arch Neurol, October 1, 2006; 63(10): 1372 - 1376. [Abstract] [Full Text] [PDF]

				E. Pomarol-Clotet, G. D. Honey, G. K. Murray, P. R. Corlett, A. R. Absalom, M. Lee, P. J. McKenna, E. T. Bullmore, and P. C. Fletcher Psychological effects of ketamine in healthy volunteers: Phenomenological study The British Journal of Psychiatry, August 1, 2006; 189(2): 173 - 179. [Abstract] [Full Text] [PDF]

				M. O. Cunningham, J. Hunt, S. Middleton, F. E. N. LeBeau, M. G. Gillies, C. H. Davies, P. R. Maycox, M. A. Whittington, and C. Racca Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. J. Neurosci., March 8, 2006; 26(10): 2767 - 2776. [Abstract] [Full Text] [PDF]

				G.D. Honey, R.A.E. Honey, C. O'Loughlin, S.R. Sharar, D. Kumaran, J. Suckling, D.K. Menon, C. Sleator, E.T. Bullmore, and P.C. Fletcher Ketamine Disrupts Frontal and Hippocampal Contribution to Encoding and Retrieval of Episodic Memory: An fMRI Study Cereb Cortex, June 1, 2005; 15(6): 749 - 759. [Abstract] [Full Text] [PDF]

				M. J. Hunt, K. Kessal, and R. Garcia Ketamine Induces Dopamine-Dependent Depression of Evoked Hippocampal Activity in the Nucleus Accumbens in Freely Moving Rats J. Neurosci., January 12, 2005; 25(2): 524 - 531. [Abstract] [Full Text] [PDF]

				I. L. Petrakis, D. Limoncelli, R. Gueorguieva, P. Jatlow, N. N. Boutros, L. Trevisan, J. Gelernter, and J. H. Krystal Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to Alcoholism Am J Psychiatry, October 1, 2004; 161(10): 1776 - 1782. [Abstract] [Full Text] [PDF]

				B. MOGHADDAM and M. E. JACKSON Glutamatergic Animal Models of Schizophrenia Ann. N.Y. Acad. Sci., November 1, 2003; 1003(1): 131 - 137. [Abstract] [Full Text] [PDF]

				M. T. Avila, M. A. Weiler, A. C. Lahti, C. A. Tamminga, and G. K. Thaker Effects of Ketamine on Leading Saccades During Smooth-Pursuit Eye Movements May Implicate Cerebellar Dysfunction in Schizophrenia Am J Psychiatry, September 1, 2002; 159(9): 1490 - 1496. [Abstract] [Full Text] [PDF]

				D. Umbricht, L. Schmid, R. Koller, F. X. Vollenweider, D. Hell, and D. C. Javitt Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers: Implications for Models of Cognitive Deficits in Schizophrenia Arch Gen Psychiatry, December 1, 2000; 57(12): 1139 - 1147. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1999 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us